• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    CTI BioPharma Corp. (CTIC)

    -NasdaqCM
    1.82 Down 0.09(4.71%) Apr 17, 4:00PM EDT
    |After Hours : 1.82 Down 0.00 (0.01%) Apr 17, 4:22PM EDT
    Add to Portfolio
    Prev Close:1.91
    Open:1.88
    Bid:1.82 x 1000
    Ask:1.90 x 1000
    1y Target Est:5.63
    Beta:1.64
    Earnings Date:Apr 27 - May 1 (Est.)
    Day's Range:1.82 - 1.88
    52wk Range:1.77 - 3.36
    Volume:1,272,140
    Avg Vol (3m):3,526,080
    Market Cap:316.15M
    P/E (ttm):N/A
    EPS (ttm):-0.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CTIC

    Comparison

    Symbol% ChgMkt Cap
    CTICDown 4.71%316.15M
    BMYUp 2.62%108.62B
    RHHBYDown 1.53%N/A
    SNYDown 0.88%135.14B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.52
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.46
    Quarterly EPS Est (Mar-15) :-0.14
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback